医学
放射治疗
医学物理学
临床试验
重症监护医学
放射科
内科学
作者
Edward Chow,Peter Hoskin,Gunita Mitera,Liang Zeng,S Lutz,Daniel Roos,Carol Hahn,Yvette M. van der Linden,William F. Hartsell,Eshwar Kumar
标识
DOI:10.1016/j.ijrobp.2011.02.008
摘要
Purpose
To update the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases by surveying international experts regarding previous uncertainties within the 2002 consensus, changes that may be necessary based on practice pattern changes and research findings since that time. Methods and Materials
A two-phase survey was used to determine revisions and new additions to the 2002 consensus. A total of 49 experts from the American Society for Radiation Oncology, the European Society for Therapeutic Radiology and Oncology, the Faculty of Radiation Oncology of the Royal Australian and New Zealand College of Radiologists, and the Canadian Association of Radiation Oncology who are directly involved in the care of patients with bone metastases participated in this survey. Results
Consensus was established in areas involving response definitions, eligibility criteria for future trials, reirradiation, changes in systemic therapy, radiation techniques, parameters at follow-up, and timing of assessments. Conclusion
An outline for trials in bone metastases was updated based on survey and consensus. Investigators leading trials in bone metastases are encouraged to adopt the revised guideline to promote consistent reporting. Areas for future research were identified. It is intended for the consensus to be re-examined in the future on a regular basis.
科研通智能强力驱动
Strongly Powered by AbleSci AI